Life Sciences and Health Сare surveys, reports, infographics, case studies and more

Վերլուծական նյութեր

Publications archive

Life Sciences and Health Сare surveys, reports, infographics, case studies and more

Դիտել բովանդակությունը

Archive 2015

Measuring the return from pharmaceutical innovation 2015

Transforming R&D returns in uncertain times

Macroeconomic pressures have hit the R&D returns of life sciences firms, according to new Deloitte research. The sixth annual pharmaceutical innovation study looks at the challenges the industry faces in generating returns from its R&D investments, while highlighting lessons that can be learned...More

Development Trends and Practical Aspects of the Russian Pharmaceuti­cal Industry – 2015

Survey results

Since the end of 2014, the Russian pharmaceutical industry has been affected by the overall economic situation in the country (devaluation of the national currency, economic slowdown and decreasing purchasing power of the population etc.) and the global geopolitical situation (sanctions imposed against Russia, etc.)...More

2015 Global life sciences sector outlook

Adapting in an era of transforma­tion

Aging populations, chronic/lifestyle diseases, emerging-market expansion, and treatment and technology advances are expected to spur the life sciences sector’s growth in 2015. However, efforts by governments, health care providers, and health plans to reduce costs, improve outcomes, and demonstrate value is dramatically altering the health care demand and delivery landscape. It is becoming increasingly evident that the global life sciences sector is operating in an era of significant transformation...More

Archive 2014

2014 Global health care sector outlook

Shared challenges, shared opportunities

The coming years look to be a positive but challenging time for the global health care sector; one in which many historic business models and operating processes will no longer suffice amid rising demand, continued cost pressures, lack of or inadequate care facilities, and rapidly evolving market conditions...More

Life sciences accounting and financial reporting update

March, 2014

Deloitte is pleased to present the life sciences industry’s fifth annual accounting and financial reporting update. This publication highlights specialized accounting and reporting considerations applicable to companies in this industry...More

Competitive­ness: Catching the next wave

China

China has the opportunity to be a world leader in a number of important areas that will be cornerstones of global growth in the decades to come. This latest report in Deloitte’s competitiveness series aims to put China’s history of growth into broader perspective, and identify key industry sectors that will help power the nation’s “next wave” of sustainable growth...More

Adam Smith Conferences’ Russian Pharmaceutical Forum

Adam Smith Conferences’ Russian Pharmaceutical Forum took place on 17 – 19 June 2014 in St. Petersburg...More

Archive 2013

Deloitte ranked #1 worldwide, based on revenue, in Life Sciences Consulting by Kennedy

According to the report, Deloitte’s post-transaction services, regulatory and risk expertise and commercial operating models are its strengths. Kennedy notes that “Deloitte provides one of the widest ranges of capability in the industry and the relationship models to support large program initiatives...More

Դիտել բովանդակությունը

Did you find this useful?